Subject matter expertise to advance our work
Much of CAPCA’s work is advanced by standing committees aligned to its initiatives. Each committee is led by a chair or co-chair and is comprised of subject matter experts including medical professionals, people with lived experience, and representatives from relevant professional associations and healthcare organizations.
Canadian Partnership for Quality Radiotherapy (CPQR)
Established in 2010 as an independent organization funded by the Canadian Partnership Against Cancer, CPQR has significantly improved the safety and quality of radiotherapy in Canada. Since 2021, CPQR has been a steering committee of CAPCA, where it is advancing our work on Radiotherapy Quality and Access.
Improving radiotherapy delivery
National Immune Effector Cell (IEC) Therapy Consensus Advisory Committee
The National IEC Therapy Consensus Advisory Committee is advancing CAPCA’s work on Immune Effector Cell Therapy Access and Quality. It brings together clinicians with expertise in IEC therapy and blood disorders to create a common standard for adult patient care.
Standardizing treatment for blood cancers
Learn about our work to advance IEC therapy access and quality.
Pan-Canadian Quality Radiopharmaceutical Committee (pCQRT)
pCQRT is working to advance CAPCA’s Radiopharmaceutical Quality Assurance initiative. Its membership reflects the diverse expertise of healthcare professionals involved in radiopharmaceutical therapy including nuclear medicine physicians, radiation oncologists, radiopharmacists, and medical oncologists.
Advancing radiopharmaceutical therapy
Find out more about our work on quality assurance in radiopharmaceutical therapy.
